Showing results (201-210 of 236) with videos related to

Sort By:
Pageof 24
Oncoimmunology|August 16, 2025
Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitorsNora Möhn, Emily Narten, Laura Duzzi, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 17, 2025
Neural autoantibodies in psychiatric disorders are associated with antibodies against viral pathogens: a retrospective study of 619 patientsNiels Hansen, Vincent Buschatzky, Anne Katharina Bastin, et al.
Neurology and Therapy|March 9, 2026
Divergent Immunological and Neurotrophic Responses to CD20 Depletion in Relapsing and Progressive Multiple SclerosisGudrun M Körner, Thiemo M Möllenkamp, Konstantin F Jendretzky, et al.
Neurological Research and Practice|November 13, 2024
Prevalence of comorbid autoimmune diseases and antibodies in newly diagnosed multiple sclerosis patientsKonstantin Fritz Jendretzky, Lisa-Marie Lezius, Thea Thiele, et al.
Scientific Reports|October 7, 2025
Polyneuropathy in hereditary and wildtype transthyretin amyloidosis, comparison of key clinical features and red flagsJanna M Siemer, Lea Grote-Levi, Anja Hänselmann, et al.
Clinical Chemistry and Laboratory Medicine|March 31, 2009
Phenotyping of congenic dipeptidyl peptidase 4 (DP4) deficient Dark Agouti (DA) rats suggests involvement of DP4 in neuro-, endocrine, and immune functionsNadine Frerker, Kerstin Raber, Felix Bode, et al.
Annals of Clinical and Translational Neurology|December 19, 2023
Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosisAhmed Abdelhak, Kai Antweiler, Markus C Kowarik, et al.
Oncology Research|May 1, 2026
Elevated C-Reactive Protein as a Potential Biomarker for Neurological Adverse Events in Immune Checkpoint Inhibitor Therapy: A Prospective Cohort StudyLaura Duzzi, Nora Möhn, Emily Narten, et al.
Cancer Medicine|January 26, 2025
Characterization of Hospital Admissions During Immune Checkpoint Inhibitor Therapy: Insights From the ICOG StudyJonas Paul Wiegmann, Tabea Fröhlich, Nora Möhn, et al.
Autoimmunity Reviews|January 22, 2025
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disordersFranz Felix Konen, Nora Möhn, Torsten Witte, et al.
Pageof 24